ReShape Lifesciences, Inc. (RSLS)
RSLS moved a median of -0.61% 30 minutes after news, and -1.60% by the close. How RSLS actually reacts to news — the realized, point-in-time move the market made, measured across 175 labeled events over the last three years with zero look-ahead.
RSLS’s median reaction, across the day.
| Horizon | Median | % positive | Events |
|---|---|---|---|
| 5-min | -0.32% | 36% | 165 |
| 30-min | -0.61% | 39% | 167 |
| 60-min | -0.41% | 45% | 169 |
| to close | -1.60% | 39% | 167 |
| Middle 50% of RSLS reactions | -3.31% to +1.96% |
|---|---|
| Median reaction (30-min) | -0.61% |
| Measured reactions | 175 |
Half of all ReShape Lifesciences, Inc. news events land between -3.31% and +1.96% at 30 minutes.
Reaction stats as of 2026-09-21. Newest measured event . Reaction = percent move vs. the price at the news timestamp.
Email me when RSLS moves on news.
One email per qualifying move — the headline, the measured reaction, and how it compares to RSLS's baseline. Nothing else.
Recent RSLS events, each with its measured reaction.
| Date | Headline | Event | Source | 5-min | To close |
|---|---|---|---|---|---|
| Form 8-K Vyome Holdings, Inc For: Aug 18 | SEC filing · Form 8-K | SEC EDGAR | — | — | |
| Form 8-K Vyome Holdings, Inc For: Aug 13 | SEC filing · Form 8-K | SEC EDGAR | — | — | |
| Form 10-Q ReShape Lifesciences For: Jun 30 | SEC filing · Form 10-Q | SEC EDGAR | — | — | |
| Vyome closes Merger Transaction, Will Trade on Nasdaq as HIND Tomorrow | Press release | Business Wire | — | — | |
| Vyome Announces Nasdaq Approval of Merger with ReShape Lifesciences, Set to Begin Trading as HIND | Press release | Business Wire | +10.19% | +48.15% | |
| Vyome Announces New Board of Directors with Deep MIT and AI Ties | Press release | Business Wire | -0.60% | — | |
| Form 8-K ReShape Lifesciences For: Aug 07 | SEC filing · Form 8-K | SEC EDGAR | +0.01% | — | |
| ReShape Lifesciences Announces Shareholder Approval of Merger with Vyome Therapeutics | Press release | Business Wire | -0.86% | -3.86% | |
| Form 8-K ReShape Lifesciences For: Jul 24 | SEC filing · Form 8-K | SEC EDGAR | +1.24% | -0.83% | |
| ReShape Lifesciences® Announces Partial Adjournment of Special Meeting of Stockholders | Press release | GlobeNewswire | -3.46% | -4.25% | |
| ReShape Lifesciences® to Host Inaugural Lap-Band® Surgeon Summit | Press release | GlobeNewswire | -1.37% | +3.42% | |
| ReShape Lifesciences® to Host Special Meeting of Stockholders on July 24, 2025 | Press release | GlobeNewswire | -0.14% | -3.80% | |
| Form 8-K ReShape Lifesciences For: Jul 15 | SEC filing · Form 8-K | SEC EDGAR | -4.07% | +5.60% | |
| Form 8-K ReShape Lifesciences For: Jun 27 | SEC filing · Form 8-K | SEC EDGAR | +0.43% | +1.28% | |
| ReShape Lifesciences® Granted U.S. Patent Related to an Intragastric Balloon System | Press release | GlobeNewswire | +0.88% | +2.10% | |
| ReShape Lifesciences® Regains Compliance with Nasdaq Minimum Stockholders Equity Requirement | Press release | GlobeNewswire | +1.25% | +3.39% | |
| ReShape Lifesciences® Announces Strategic Cost Reductions and Provides Update on the Merger Agreement with Vyome Therapeutics and Asset Purchase Agreement with Biorad Medisys | Press release | GlobeNewswire | +1.73% | -2.86% | |
| ReShape Lifesciences® Granted Key International Patent in Australia for Its Proprietary Diabetes Neuromodulation Technology | Press release | GlobeNewswire | -2.38% | -16.61% | |
| Form EFFECT ReShape Lifesciences | SEC filing · Form EFFECT | SEC EDGAR | +0.80% | +2.40% | |
| Form 8-K ReShape Lifesciences For: Jun 18 | SEC filing · Form 8-K | SEC EDGAR | -0.78% | -1.16% | |
| Form POS AM ReShape Lifesciences | SEC filing · Form POS | SEC EDGAR | -2.10% | -6.32% | |
| Form 8-K ReShape Lifesciences For: Jun 08 | SEC filing · Form 8-K | SEC EDGAR | -0.37% | -6.32% | |
| ReShape Lifesciences® Signs Exclusive Distribution Agreement with Recon Supply to Access the VA and DoD Markets | Press release | GlobeNewswire | +2.37% | +5.42% | |
| Form 8-K ReShape Lifesciences For: Jun 09 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | +8.33% | |
| ReShape Lifesciences® Announces Pricing of $2.6 Million Public Offering | Press release | GlobeNewswire | -3.66% | +6.56% | |
| ReShape Lifesciences® Announces EU MDR Certification for Entire European and United Kingdom Product Portfolio | Press release | GlobeNewswire | -4.06% | +19.05% | |
| Form 8-K ReShape Lifesciences For: May 28 | SEC filing · Form 8-K | SEC EDGAR | +4.14% | +6.95% | |
| Form 8-K ReShape Lifesciences For: May 30 | SEC filing · Form 8-K | SEC EDGAR | +4.14% | +6.95% | |
| Form 8-K ReShape Lifesciences For: May 28 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | -2.14% | |
| ReShape Lifesciences® Reports First Quarter Ended March 31, 2025 Financial Results and Provides Corporate Update | Press release | GlobeNewswire | +3.36% | -11.72% | |
| Form 10-Q ReShape Lifesciences For: Mar 31 | SEC filing · Form 10-Q | SEC EDGAR | +3.36% | -11.72% | |
| Form EFFECT ReShape Lifesciences | SEC filing · Form EFFECT | SEC EDGAR | -1.67% | -0.17% | |
| Form NT 10-Q ReShape Lifesciences For: Mar 31 | SEC filing · Form NT | SEC EDGAR | -1.94% | +5.02% | |
| Form S-4/A ReShape Lifesciences | SEC filing · Form S-4 | SEC EDGAR | -1.62% | -2.10% | |
| Form 8-K ReShape Lifesciences For: May 06 | SEC filing · Form 8-K | SEC EDGAR | +5.82% | +6.00% | |
| Form S-3 ReShape Lifesciences | SEC filing · Form S-3 | SEC EDGAR | +5.82% | +6.00% | |
| Form S-4/A ReShape Lifesciences | SEC filing · Form S-4 | SEC EDGAR | +5.82% | +6.00% | |
| ReShape Lifesciences Announces 1-for-25 Reverse Stock Split | Press release | GlobeNewswire | -0.14% | +1.03% | |
| ReShape Lifesciences® Presents Pre-clinical Data on Its Proprietary Diabetes Neuromodulation Device at the 12th Annual Minnesota Neuromodulation Symposium | Press release | GlobeNewswire | -10.33% | -23.45% | |
| Form S-4/A ReShape Lifesciences | SEC filing · Form S-4 | SEC EDGAR | -1.75% | -1.57% | |
| Form 8-K ReShape Lifesciences For: Apr 25 | SEC filing · Form 8-K | SEC EDGAR | -1.75% | -1.57% | |
| ReShape Lifesciences® Receives Notice of Allowance for Key U.S. Patent Related to an Intragastric Balloon System | Press release | GlobeNewswire | +1.65% | -2.19% | |
| Form 8-K ReShape Lifesciences For: Apr 15 | SEC filing · Form 8-K | SEC EDGAR | +4.46% | +0.08% | |
| ReShape Lifesciences® Receives Notice of Allowance for Additional U.S. Patent Related to Its Proprietary Diabetes Neuromodulation Technology | Press release | GlobeNewswire | -8.93% | -16.97% | |
| ReShape Lifesciences® Partners with Motion Informatics to Bring AI-Driven Neurorehabilitation Technology to the U.S. Market | Press release | GlobeNewswire | -15.49% | -15.05% | |
| ReShape Lifesciences® Reports Year Ended December 31, 2024 Financial Results and Provides Corporate Update | Press release | GlobeNewswire | -1.69% | -19.02% | |
| Form 10-K ReShape Lifesciences For: Dec 31 | SEC filing · Form 10-K | SEC EDGAR | +0.02% | -5.80% | |
| Form 8-K ReShape Lifesciences For: Apr 01 | SEC filing · Form 8-K | SEC EDGAR | -3.66% | -30.16% | |
| Form NT 10-K ReShape Lifesciences For: Dec 31 | SEC filing · Form NT | SEC EDGAR | -3.66% | -30.16% | |
| Form 8-K ReShape Lifesciences For: Mar 14 | SEC filing · Form 8-K | SEC EDGAR | -1.73% | -1.63% |
Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the RSLS section they belong to.
Where else RSLS is measured.
RSLS earnings → · Analyst actions → · SEC filings →
Other Healthcare names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Capstone Holding Corp. (CAPS) | 175 | -2.00% | 35% |
| Ekso Bionics Holdings, Inc. (EKSO) | 175 | -0.12% | 39% |
| EDAP TMS S.A. - American Depositary Shares, each representing One Ordinary Share (EDAP) | 174 | 0.00% | 45% |
| EVIO INC (EVIO) | 174 | 0.00% | 43% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.
All Healthcare names, measured the same way →
Every ticker we measure the same way24
Apple (AAPL)
How AAPL actually reacts to news, measured.
NVIDIA (NVDA)
How NVDA actually reacts to news, measured.
Tesla (TSLA)
How TSLA actually reacts to news, measured.
Microsoft (MSFT)
How MSFT actually reacts to news, measured.
Advanced Micro Devices (AMD)
How AMD actually reacts to news, measured.
Amazon (AMZN)
How AMZN actually reacts to news, measured.
Alphabet (GOOG)
How GOOG actually reacts to news, measured.
Meta Platforms (META)
How META actually reacts to news, measured.
Broadcom (AVGO)
How AVGO actually reacts to news, measured.
JPMorgan Chase (JPM)
How JPM actually reacts to news, measured.
Visa (V)
How V actually reacts to news, measured.
Walmart (WMT)
How WMT actually reacts to news, measured.
Eli Lilly (LLY)
How LLY actually reacts to news, measured.
UnitedHealth Group (UNH)
How UNH actually reacts to news, measured.
Netflix (NFLX)
How NFLX actually reacts to news, measured.
Johnson & Johnson (JNJ)
How JNJ actually reacts to news, measured.
Exxon Mobil (XOM)
How XOM actually reacts to news, measured.
Home Depot (HD)
How HD actually reacts to news, measured.
Costco (COST)
How COST actually reacts to news, measured.
Mastercard (MA)
How MA actually reacts to news, measured.
Oracle (ORCL)
How ORCL actually reacts to news, measured.
Salesforce (CRM)
How CRM actually reacts to news, measured.
Bank of America (BAC)
How BAC actually reacts to news, measured.
Coca-Cola (KO)
How KO actually reacts to news, measured.
Walt Disney (DIS)
How DIS actually reacts to news, measured.
Browse all tickers
Every name we’ve measured, in one place.
How the numbers are made.
How is ReShape Lifesciences, Inc.'s median reaction calculated?
Every labeled RSLS news event is measured from its own timestamp: the last trade before the news is the base price, and the move is read at fixed horizons — 30 minutes of trading, then the close. The median across 175 events is what this page reports. Point-in-time, zero look-ahead: no event borrows information from a later one.
What counts as a positive reaction?
Any event whose price move is above zero at the horizon, relative to the last trade before the news timestamp. 39% of RSLS's measured events are up at 30 minutes; the rest close the window flat or negative.
How often is this page updated?
The news table refreshes automatically as new events are labeled and priced. The reaction medians are re-pulled in batches from the dataset — the figures here are as of 2026-09-21.
Does RSLS's past reaction predict its next one?
No. These are realized facts about past events, not forecasts. They describe a distribution — they say nothing certain about any future move.